Belimumab After Rituximab in Resistant Primary Juvenile SS (BRRPJS)
Effectiveness of Belimumab After Rituximab in Resistant Primary Juvenile Sjogren's Syndrome
Sponsor: Central South University
A PHASE4 clinical study on Pediatric ALL and Sjogren's Syndrome, this trial is actively recruiting participants. The trial is conducted by Central South University and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE4
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central South University
- Children's Hospital of Chongqing Medical University
- Children's Hospital of Fudan University
- Children's Hospital of Nanjing Medical University
- Children's Hospital of The Capital Institute of Pediatrics
- Peking Union Medical College Hospital
- Shanghai Children's Hospital
- Shengjing Hospital
- Shenzhen Children's Hospital
- The Affiliated Hospital of Qingdao University
- The First Hospital of Jilin University
- Tianjin Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .